Parkinson’s disease may be treated with implantation of devices

Deep Brain Stimulation devices

According to recent research by neurologists, implantation of Deep Brain Stimulation (DBS) devices in an early stage of Parkinson’s disease can significantly reduce the tremors and other symptoms of widespread neurodegenerative disease that occurs mostly, in people over 60 years.

The study was published in the prestigious magazine New England Journal of Medicine, and it is likely that the practice actually end up being made worldwide. So far, the implantation of an electrical stimulation device is used only as a last resort, when the medication is not effective.

DBS devices, implanted under the thalamus of the brain to treat Parkinson’s disease was first used in 1993. The Food and Drug Administration of the United States approved its use in 2001.

In 2005 this procedure was included in the basket of health services in Israel. According to Dr. Zvi Israel, a lecturer in neurosurgery at the Hadassah University Medical Center in Jerusalem’s Ein Kerem, “the DBS have so far been reserved for patients with very advanced disease who have already developed complications of therapy care. The DBS back the clock on the disease for these patients for many years. Sometimes the effects are very dramatic. Most patients enjoy a better quality of life, often regaining their independence and reduce their medication by an average of 50 percent.”